Interv Akut Kardiol. 2015;14(1):35-36

Closure of persistent arterial duct in patient with hypoplastic femoral arteries

Marek Kardoš, Peter Tittel
Oddelenie funkčného vyšetrovania, Detské kardiocentrum, Bratislava

Persistent arterial duct (PDA) is one of the most common congenital heart diseases. Catheter-based closure of PDA represents an excelent

therapeutic method. We present a case of catheter-based closure of PDA in patient with hypoplastic femoral arteries confirmed

sonographically. Only venous access was used during catheterization which complicated angiographic visualization of PDA and then

choice of right type and size of Amplatzer occluder.

Keywords: persistent arterial duct, transcatheter closure, hypoplastic femoral arteries

Published: April 20, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kardoš M, Tittel P. Closure of persistent arterial duct in patient with hypoplastic femoral arteries. Interv Akut Kardiol. 2015;14(1):35-36.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Forsey Jonathan T, Elmasry Ola A, and Martin Robin P. Patent arterial duct. Orphanet Rare J Dis. 2009; 4: 17. Go to original source... Go to PubMed...
    2. Benson LN, Cowan KN. The arterial duct: its persistence and its patency. In: Anderson RH, Baker EJ, Macartney FJ, Rigby ML, Shinebourne EA, Tynan M, editor. Paediatric Cardiology. second. Churchill Livingstone, London; 2002: 1405-1459.
    3. Krichenko A, Benson L, Burrows P, Moes C, McLaughlin P, Freedom R. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989; 63: 877-879. Go to original source... Go to PubMed...
    4. Fismol J, Januška J, Škňouřil L, et al. Persistent ductus arteriosus as a rare cause of severe pulmonary hypertension in elderly patients. Interv Akut Kardiol 2009; 8: 144-147.
    5. Masura, J, Gavora, P, Podnar T. Transcatheter occlusion of patent ductus arteriosus using a new angled Amplatzer duct occluder: Initial clinical experience. Catheterization and Cardiovascular Interventions, 2003; 58: 261-267. Go to original source... Go to PubMed...
    6. Podnar T, Gavora P, Masura J. Percutaneous closure of patent ductus arteriosus: complementary use of detachable Cook patent ductus arteriosus coils and Amplatzer duct occluders. European Journal of Pediatrics, 2000; 159: 293-296. Go to original source... Go to PubMed...
    7. Venczelova Z, Tittel P, Masura J. The new Amplatzer duct occluder II: when is its use advantageous? Cardiol Young. 2011;21: 495-504. Go to original source... Go to PubMed...
    8. Masura J, Tittel P, Gavora P, Podnar T. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. American Heart Journal, 2006; 151: 7-10. Go to original source... Go to PubMed...
    9. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol. 2004; 44: 513-519. Go to original source...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.